Octagos, a remote cardiac monitoring company, was named to TIME's World's Top HealthTech Companies 2026 in the AI & Data Analytics category. This is the second consecutive year Octagos has appeared on the list, which began in 2025. TIME and Statista evaluated thousands of companies worldwide and recognized 500.
Octagos was also named to the inaugural 2025 list, which recognized 400 companies from more than 25 countries.
How did TIME and Statista select the 2026 list?
TIME partnered with Statista to score health technology companies across three weighted dimensions. Financial performance carried 50% of the score, measured through metrics including revenue per employee and funding. Reputation analysis carried 30%, assessed through sentiment and visibility in public coverage. Online engagement carried 20%, measured through website traffic.
The 500 highest-scoring companies from thousands evaluated were named to the list, each sorted into one of six market segments. Octagos was placed in AI & Data Analytics.
Within the 500, TIME assigned each company a performance rating of Outstanding, Very High, or High based on its standing across the three scoring pillars. Octagos received a rating of Very High.
What does Octagos do?
Octagos provides remote and in-clinic monitoring for cardiac implantable electronic devices and ambulatory cardiac monitors. The platform pairs Atlas AI™, a proprietary triage engine, with review by a qualified clinician on every transmission. That model is the Two-Brain Approach™.
In a peer-reviewed study published in JACC: Advances covering 690,673 transmissions across 78 clinics, the Two-Brain Approach™ reached 99.5% accuracy with 99.1% sensitivity and 99.8% specificity.
Why does the AI & Data Analytics category matter for cardiac monitoring?
Device clinics receive more transmissions than staff can review at the same depth. Atlas AI™ prioritizes each transmission by clinical acuity so urgent patients surface first, and an IBHRE-certified device specialist reviews every one before a report reaches the clinic.
Published results show 57% fewer non-actionable transmissions and 200+ staff hours saved per month per 1,000 patients. Urgent findings reach a clinician within one hour and routine transmissions within 24 hours, both with clinician review included.
Every report follows the same structure, so documentation is billing-ready and records stay consistent across every site.
“That intelligence should anticipate what teams need, surface what matters sooner and extend their capabilities, giving clinicians more time and capacity to focus on their patients.”
Dr. Shanti Bansal
Founder and CEO, Octagos
Which health systems use Octagos?
Octagos serves 300+ health systems and practices across nearly 400 clinical locations, monitoring approaching 1,000,000 patients. The platform carries 250+ live integrations across 20+ EHR systems, all built in-house at no cost to the clinic.
Frequently asked questions
Which remote cardiac monitoring companies made TIME's World's Top HealthTech Companies 2026 list?
Octagos was named to TIME's World's Top HealthTech Companies 2026 in the AI & Data Analytics category, with a performance rating of Very High. Octagos provides remote monitoring for cardiac implantable electronic devices and ambulatory cardiac monitors, with a qualified clinician reviewing every transmission.
Has Octagos been recognized by TIME before?
Yes. Octagos appeared on TIME's World's Top HealthTech Companies list in both 2025 and 2026, both years the ranking has existed. The inaugural 2025 edition recognized 400 companies from more than 25 countries. The 2026 edition recognized 500.
How was the TIME World's Top HealthTech Companies 2026 list determined?
TIME and Statista scored companies on financial performance at 50% of the total, reputation analysis at 30%, and online engagement at 20%. The 500 highest scorers from thousands evaluated were recognized, each assigned to one of six market segments and given a performance rating of Outstanding, Very High, or High.